ADC Therapeutics SA (ADCT) Stock: Why It's Up Today
Updated Oct 20, 2026, 11:31 AM ET · intraday price
- Trading at $1.50 as of 11:31 AM ET, +3.82% vs the prior close of $1.44.
- Volume 275.33K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ADCT jumps 3.8% to $1.50. Trading at $1.50 (intraday, 11:31 AM ET), +3.82% vs the prior close of $1.44. Day range $1.43–$1.52, opened at $1.45.
ADCT daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — ADCT jumps 3.8% to $1.50
- Trading at $1.50 (intraday, 11:31 AM ET), +3.82% vs the prior close of $1.44. Day range $1.43–$1.52, opened at $1.45.
- Volume was 275.33K shares, 0.2x its 50-day average of 1.72M — lighter than usual.
- Price is +21.4% vs its 50-day average ($1.23) and -41.7% vs its 200-day average ($2.56).
- 52-week range $0.78–$4.98; the current price sits at 17% of that range, 70.0% below the 52-week high.
Oct 19, 2026 — ADCT rises 2.9% to $1.44
- Closed at $1.44, +2.86% vs the prior close of $1.40. Day range $1.40–$1.49, opened at $1.40.
- Volume was 572.62K shares, 0.3x its 50-day average of 1.72M — lighter than usual.
- Price is +17.6% vs its 50-day average ($1.22) and -44.1% vs its 200-day average ($2.57).
- 52-week range $0.78–$4.98; today's close sits at 16% of that range, 71.1% below the 52-week high.
Oct 16, 2026 — ADCT slides 6.0% to $1.40
- Closed at $1.40, -6.04% vs the prior close of $1.49. Day range $1.40–$1.51, opened at $1.49.
- Volume was 799.51K shares, 0.5x its 50-day average of 1.72M — lighter than usual.
- Price is +14.9% vs its 50-day average ($1.22) and -45.8% vs its 200-day average ($2.59).
- 52-week range $0.78–$4.98; today's close sits at 15% of that range, 71.9% below the 52-week high.
Oct 15, 2026 — ADCT rises 2.8% to $1.49
- Closed at $1.49, +2.76% vs the prior close of $1.45. Day range $1.46–$1.57, opened at $1.47.
- Volume was 1.33M shares, 0.8x its 50-day average of 1.71M.
- Price is +22.8% vs its 50-day average ($1.21) and -42.6% vs its 200-day average ($2.60).
- 52-week range $0.78–$4.98; today's close sits at 17% of that range, 70.1% below the 52-week high.
Oct 14, 2026 — ADCT slides 14.7% to $1.45
- Closed at $1.45, -14.71% vs the prior close of $1.70. Day range $1.40–$1.73, opened at $1.67.
- Volume was 1.74M shares, 1.0x its 50-day average of 1.71M.
- Price is +20.4% vs its 50-day average ($1.20) and -44.4% vs its 200-day average ($2.61).
- 52-week range $0.78–$4.98; today's close sits at 16% of that range, 70.9% below the 52-week high.
Oct 13, 2026 — ADCT slides 8.6% to $1.70 on 2.0x normal volume
- Closed at $1.70, -8.60% vs the prior close of $1.86. Day range $1.62–$1.86, opened at $1.86.
- Volume was 3.32M shares, 2.0x its 50-day average of 1.66M — unusually heavy trading.
- Price is +41.9% vs its 50-day average ($1.20) and -35.0% vs its 200-day average ($2.62).
- 52-week range $0.78–$4.98; today's close sits at 22% of that range, 65.9% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 12, 2026 — ADCT jumps 7.5% to $1.86, a 3-month high, 7 up days in a row
- Closed at $1.86, +7.51% vs the prior close of $1.73. Day range $1.64–$1.87, opened at $1.70.
- Volume was 1.59M shares, 1.0x its 50-day average of 1.64M.
- Price is +57.0% vs its 50-day average ($1.18) and -29.2% vs its 200-day average ($2.63).
- 52-week range $0.78–$4.98; today's close sits at 26% of that range, 62.7% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — ADCT jumps 8.8% to $1.73, a 3-month high on 2.0x normal volume
- Closed at $1.73, +8.81% vs the prior close of $1.59. Day range $1.56–$1.83, opened at $1.58.
- Volume was 3.14M shares, 2.0x its 50-day average of 1.59M — unusually heavy trading.
- Price is +48.1% vs its 50-day average ($1.17) and -34.3% vs its 200-day average ($2.63).
- 52-week range $0.78–$4.98; today's close sits at 23% of that range, 65.3% below the 52-week high.
- That makes 6 straight gains.
Oct 8, 2026 — ADCT jumps 12.0% to $1.59, a 3-month high on 3.7x normal volume
- Closed at $1.59, +11.97% vs the prior close of $1.42. Day range $1.32–$1.63, opened at $1.41.
- Volume was 5.55M shares, 3.7x its 50-day average of 1.50M — unusually heavy trading.
- Price is +37.5% vs its 50-day average ($1.16) and -39.8% vs its 200-day average ($2.64).
- 52-week range $0.78–$4.98; today's close sits at 19% of that range, 68.1% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — ADCT jumps 11.8% to $1.42, a 3-month high, 4 up days in a row
- Closed at $1.42, +11.81% vs the prior close of $1.27. Day range $1.24–$1.44, opened at $1.25.
- Volume was 1.75M shares, 1.2x its 50-day average of 1.48M.
- Price is +23.9% vs its 50-day average ($1.15) and -46.5% vs its 200-day average ($2.65).
- 52-week range $0.78–$4.98; today's close sits at 15% of that range, 71.5% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — ADCT jumps 3.3% to $1.27, 3 up days in a row
- Closed at $1.27, +3.25% vs the prior close of $1.23. Day range $1.20–$1.27, opened at $1.25.
- Volume was 1.35M shares, 0.9x its 50-day average of 1.47M.
- Price is +11.4% vs its 50-day average ($1.14) and -52.4% vs its 200-day average ($2.67).
- 52-week range $0.78–$4.98; today's close sits at 12% of that range, 74.5% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — ADCT jumps 8.8% to $1.23
- Closed at $1.23, +8.85% vs the prior close of $1.13. Day range $1.11–$1.26, opened at $1.12.
- Volume was 1.75M shares, 1.2x its 50-day average of 1.45M.
- Price is +8.1% vs its 50-day average ($1.14) and -54.1% vs its 200-day average ($2.68).
- 52-week range $0.78–$4.98; today's close sits at 11% of that range, 75.3% below the 52-week high.
Oct 2, 2026 — ADCT jumps 4.6% to $1.13
- Closed at $1.13, +4.63% vs the prior close of $1.08. Day range $1.06–$1.14, opened at $1.10.
- Volume was 1.32M shares, 0.9x its 50-day average of 1.44M.
- Price is -0.5% vs its 50-day average ($1.14) and -58.0% vs its 200-day average ($2.69).
- 52-week range $0.78–$4.98; today's close sits at 8% of that range, 77.3% below the 52-week high.
ADCT bull case vs bear case (from the data)
- Price is +21.4% vs its 50-day average — short-term trend is up.
- Price is -41.7% vs its 200-day average — below the long-term trend line.
- Annual revenue fell 7.8% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $142.62M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- Share count up 13.5% in a year (dilution).
- High volatility: average daily move of 6.0% over 20 sessions.
ADCT latest news & SEC filings
Every SEC filing by or about ADCT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
- Item 3.02 — Sold unregistered shares.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $18.63M (prior year $18.09M) (+3.0% vs Jun 30, 2025)
- Net income: -$16.57M (prior year -$56.65M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.11 (prior year -$0.50) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade ADCT
- Last results release: Oct 13, 2026 (8-K Item 2.02). Previous ones: Aug 13, 2026, May 4, 2026, Mar 10, 2026. Based on that rhythm, the next report is likely around Jan 12, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.03% (largest 14.7%). That is a volatile stock.
- Liquidity: about 1.64M shares (≈$2.44M) trade per day on average.
- 52-week position: $1.50 vs a range of $0.78–$4.98 (17% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Ii Master Fund, L.P. Redco sold 2,634,506 shares on Apr 2, 2026.
- Latest filings: 8-K Oct 13, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 127.67M shares outstanding (Aug 3, 2026), +13.5% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
ADCT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.45 | 1.52 | 1.43 | 1.50 | 275.33K |
| Oct 19, 2026 | 1.40 | 1.49 | 1.39 | 1.44 | 572.60K |
| Oct 16, 2026 | 1.49 | 1.51 | 1.40 | 1.40 | 799.50K |
| Oct 15, 2026 | 1.47 | 1.57 | 1.46 | 1.49 | 1.33M |
| Oct 14, 2026 | 1.67 | 1.73 | 1.40 | 1.45 | 1.74M |
| Oct 13, 2026 | 1.86 | 1.86 | 1.62 | 1.70 | 3.32M |
| Oct 12, 2026 | 1.70 | 1.87 | 1.64 | 1.86 | 1.59M |
| Oct 9, 2026 | 1.58 | 1.83 | 1.56 | 1.73 | 3.14M |
| Oct 8, 2026 | 1.41 | 1.63 | 1.32 | 1.59 | 5.55M |
| Oct 7, 2026 | 1.25 | 1.44 | 1.24 | 1.42 | 1.75M |
| Oct 6, 2026 | 1.25 | 1.27 | 1.20 | 1.27 | 1.35M |
| Oct 5, 2026 | 1.12 | 1.26 | 1.11 | 1.23 | 1.75M |
| Oct 2, 2026 | 1.10 | 1.14 | 1.06 | 1.13 | 1.32M |
| Oct 1, 2026 | 1.20 | 1.20 | 1.07 | 1.08 | 861.10K |
| Sep 30, 2026 | 1.23 | 1.28 | 1.20 | 1.22 | 1.11M |
| Sep 29, 2026 | 1.27 | 1.29 | 1.20 | 1.23 | 781.00K |
| Sep 28, 2026 | 1.24 | 1.27 | 1.20 | 1.26 | 834.60K |
| Sep 25, 2026 | 1.26 | 1.28 | 1.21 | 1.27 | 1.08M |
| Sep 24, 2026 | 1.30 | 1.31 | 1.24 | 1.29 | 1.58M |
| Sep 23, 2026 | 1.24 | 1.32 | 1.21 | 1.31 | 1.97M |
About ADC Therapeutics SA
ADC Therapeutics SA (ADCT) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in EPALINGES, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1771910.
ADCT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Azelby | Director | Jun 3, 2026 |
| Jean-Pierre Bizzari | Director | Jun 3, 2026 |
| Timothy Coughlin | Director | Jun 3, 2026 |
| Peter Hug | Director | Jun 3, 2026 |
| Ameet Mallik | Chief Executive Officer | Jul 2, 2026 |
| Viviane Monges | Director | Jun 3, 2026 |
| Victor Sandor | Director | Jun 3, 2026 |
| Ron Squarer | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jose Carmona | Chief Financial Officer | Jul 2, 2026 |
| Peter J Graham | Chief Legal Officer | Jul 2, 2026 |
| Lisa Michelle Kallebo | Chief Accounting Officer | Feb 18, 2026 |
| Ameet Mallik | Chief Executive Officer | Jul 2, 2026 |
| Mohamed Zaki | Chief Medical Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Jeremy Green | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Jeremy Green | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Jeremy Green | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Jeremy Green | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Group, Llc Redmile | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Group, Llc Redmile | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Group, Llc Redmile | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Group, Llc Redmile | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Ii Master Fund, L.P. Redco | Sale | 2,634,506 | $3.28 |
ADCT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-142.62M | -1.12 | $-141.17M |
| Dec 31, 2024 | — | $-157.85M | -1.62 | $-123.83M |
| Dec 31, 2023 | $69.06M | $-240.05M | -2.94 | $-118.69M |
| Dec 31, 2022 | $74.91M | $-157.13M | -2.01 | $-138.31M |
Latest balance sheet: total assets $279.38M, total liabilities $507.58M, cash $219.11M (as of Jun 30, 2026).
ADCT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 13, 2026 | 8-K Item 2.02 (results) | $1.70 |
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.05 |
| May 4, 2026 | 8-K Item 2.02 (results) | $3.68 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $4.80 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $3.57 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $4.21 |
| Oct 14, 2025 | 8-K Item 2.02 (results) | $4.11 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $2.94 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.81 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.52 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $1.72 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $2.93 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ADCT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 11:31 AM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.